Inhaled vaporized cannabis
Double-blind cannabis and placebo doses, administered through vaporizer
Loading study record…
Loading study record…
This study plans to enroll participants with opioid use disorder who are not currently seeking treatment to assess the effects of cannabis on opioid withdrawal and other related outcomes.
Locally preserved from ClinicalTrials.govOpen ClinicalTrials.govlast source update 2026-06-18
What this record can show
This locally preserved record separates the registered protocol from source-reported registry results. Neither is a treatment recommendation.
Registry facts
Linked local records
Local links use governed condition terms or exact source-reported intervention names. They are navigation candidates, not efficacy claims.
Interventions
Double-blind cannabis and placebo doses, administered through vaporizer
Double-blind opioid and placebo doses, administered intranasal route
Eligibility
primary outcomes
Time frame: Change from baseline
Subjective ratings of opioid withdrawal severity on visual analog scale (scale 0-100; 0 = not at all, 100 = extremely)
secondary outcomes
Time frame: Change from baseline
Subjective ratings of drug liking on visual analog scale (scale 0-100, 0 = not at all, 100 = extremely)
Time frame: Change from baseline
Physiological monitoring of respiration rate (breaths per minute)
Publications
No exact PMID-linked public article is currently readable locally.